Live
CellHuman-specific features of the cerebellum and ZP2-regulated synapse developmentCellCell-type-specific transposon demethylation and TAD remodeling in aging mouse brainCellPluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapyCellRespiratory viral infections prime accelerated lung cancer growthFierceBiotechInsulet, Abbott, Dexcom set sights on Type 2 diabetes at ATTDFierceBiotechVistagen lays off 20% of staff to tighten focus on struggling social anxiety candidateFierceBiotechPfizer Ignite, designed to accelerate promising biotech therapies, fizzles outScienceRelic of long-vanished ice sheet holds clues to ancient climateAgilentAgilent Expands CDMO Role With Advanced Therapeutics As Shares Lag Targets - simplywall.stPromega BlogLight Has a Favorite Color, But It’s ComplicatedEndpoints NewsPfizer to close Ignite, its R&D services unit for small biotechsFierceBiotechFledgling French biotech pens $128M deal for Kezar's preclinical protein degrader program
FierceBiotech Mar 12, 2026

Pfizer Ignite, designed to accelerate promising biotech therapies, fizzles out

Pfizer Ignite, designed to accelerate promising biotech therapies, fizzles out

Original
Body unavailable. Use the original source.

Directory

59 All